C
C. Zhou
Researcher at Wuhan University
Publications - 7
Citations - 509
C. Zhou is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 330 citations.
Papers
More filters
Journal ArticleDOI
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.
Jing Zhang,Xinghuan Wang,Xiaohua Jia,Jonathan Li,Ke Hu,George Chen,J. Wei,Z. Gong,C. Zhou,Honggang Yu,M. Yu,H. Lei,F. Cheng,B. Zhang,Yu Xu,G. Wang,Weiguo Dong +16 more
TL;DR: Being male, in severe CO VID-19 conditions, expectoration, muscle ache, and decreased albumin were independent risk factors which influence the improvement of COVID-19 patients.
Journal ArticleDOI
Consensus for HER2 alterations testing in non-small-cell lung cancer
Shengxiang Ren,J. Wang,Jianming Yang,Tetsuya Mitsudomi,D-h Lee,Z Wang,Qian Chu,Philip C. Mack,Y. Cheng,Jianchun Duan,Y. Fan,Baohui Han,Zhouguang Hui,A Liu,Ji Liu,Y. Lu,Z. Ma,Min Shi,Yongqian Shu,Qibin Song,X. Song,C. Wang,Xu Wang,Z. Wang,Y. Xu,L. Zhang,M. Zhao,B Zhu,J. Zhang,C. Zhou,Fred R. Hirsch +30 more
TL;DR: A consensus on HER2 alteration testing in non-small-cell lung cancer (NSCLC) was reached in this paper , with the focus on clinicopathologic characteristics, therapies, detection methods and diagnostic criteria for HER2-altered NSCLC patients.
Posted ContentDOI
The decay of coronavirus in sewage pipes and the development of a predictive model for the estimation of SARS-CoV-2 infection cases based on wastewater surveillance
TL;DR: Wang et al. as mentioned in this paper monitored the viral RNA abundance at one WWTP and three communities during the COVID-19 outbreak in the Yanta district of Xi'an city from December 2021 to January 2022.
Interaction between GAMs and Mean Flow Shear During SMBI Injection into HL-2A Tokamak
M. Y. Wang,C. Zhou,A.D. Liu,Gu Yuan Zhuang,X. Feng,J. Zhang,Z. Y. Liu,Junfang Ji,X.M Zhong,J. Cheng,C. Y. Chen +10 more
Journal ArticleDOI
[The dual mTORC1/2 inhibitor AZD2014 inhibits acute graft rejection in a rat liver transplantation model].
TL;DR: AZD2014 can effectively inhibit acute graft rejection in rats with allogeneic liver transplantation by inhibiting mTORC1/2 inhibitor effects on liver graft rejection.